Published on
September 3, 2019
- 10:30 GMT
Emergent BioSolutions Awarded 10-Year HHS Contract to Deliver ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) Into the Strategic ...
Reaffirms ACAM2000 as a key component of the U.S. preparedness stance against the threat of smallpox as a biologic weapon Supports the government’s continued efforts and long-term strategy to maintain sufficient quantities of smallpox vaccine to provide a …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
